Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 442

1.

α-Galactosylceramide-induced airway eosinophilia is mediated through the activation of NKT cells.

Chuang YH, Wang TC, Jen HY, Yu AL, Chiang BL.

J Immunol. 2011 Apr 15;186(8):4687-92. doi: 10.4049/jimmunol.1003659. Epub 2011 Mar 7.

2.

Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide.

Morishima Y, Ishii Y, Kimura T, Shibuya A, Shibuya K, Hegab AE, Iizuka T, Kiwamoto T, Matsuno Y, Sakamoto T, Nomura A, Taniguchi M, Sekizawa K.

Eur J Immunol. 2005 Oct;35(10):2803-14.

3.

Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.

Fujita H, Teng A, Nozawa R, Takamoto-Matsui Y, Katagiri-Matsumura H, Ikezawa Z, Ishii Y.

J Immunol. 2009 Jul 1;183(1):254-60. doi: 10.4049/jimmunol.0800520.

4.

Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.

Hogan AE, O'Reilly V, Dunne MR, Dere RT, Zeng SG, O'Brien C, Amu S, Fallon PG, Exley MA, O'Farrelly C, Zhu X, Doherty DG.

Clin Immunol. 2011 Aug;140(2):196-207. doi: 10.1016/j.clim.2011.03.016. Epub 2011 Apr 13.

PMID:
21493160
5.

Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-gamma.

Hachem P, Lisbonne M, Michel ML, Diem S, Roongapinun S, Lefort J, Marchal G, Herbelin A, Askenase PW, Dy M, Leite-de-Moraes MC.

Eur J Immunol. 2005 Oct;35(10):2793-802.

6.

Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model.

Lisbonne M, Diem S, de Castro Keller A, Lefort J, Araujo LM, Hachem P, Fourneau JM, Sidobre S, Kronenberg M, Taniguchi M, Van Endert P, Dy M, Askenase P, Russo M, Vargaftig BB, Herbelin A, Leite-de-Moraes MC.

J Immunol. 2003 Aug 15;171(4):1637-41.

7.

The development of airway hyperreactivity in T-bet-deficient mice requires CD1d-restricted NKT cells.

Kim HY, Pichavant M, Matangkasombut P, Koh YI, Savage PB, DeKruyff RH, Umetsu DT.

J Immunol. 2009 Mar 1;182(5):3252-61. doi: 10.4049/jimmunol.0803339.

8.

Poly(I:C) promotes the production of IL-17A by murine CD1d-driven invariant NKT cells in airway inflammation.

Vultaggio A, Nencini F, Pratesi S, Petroni G, Romagnani S, Maggi E.

Allergy. 2012 Oct;67(10):1223-32. doi: 10.1111/j.1398-9995.2012.02876.x.. Epub 2012 Aug 7.

9.

Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.

Bharhani MS, Chiu B, Na KS, Inman RD.

Int Immunol. 2009 Jul;21(7):859-70. doi: 10.1093/intimm/dxp052. Epub 2009 May 28.

PMID:
19477915
10.
11.
12.

alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation.

Matsuda H, Suda T, Sato J, Nagata T, Koide Y, Chida K, Nakamura H.

Am J Respir Cell Mol Biol. 2005 Jul;33(1):22-31. Epub 2005 Mar 31.

PMID:
15802553
13.

NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.

Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, Schmidt R, Harris AL, Old L, Cerundolo V.

J Immunol. 2003 Nov 15;171(10):5140-7.

14.

Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation.

Pope SM, Fulkerson PC, Blanchard C, Akei HS, Nikolaidis NM, Zimmermann N, Molkentin JD, Rothenberg ME.

J Biol Chem. 2005 Apr 8;280(14):13952-61. Epub 2005 Jan 12.

15.

Exacerbated Th2-mediated airway inflammation and hyperresponsiveness in autoimmune diabetes-prone NOD mice: a critical role for CD1d-dependent NKT cells.

Araujo LM, Lefort J, Nahori MA, Diem S, Zhu R, Dy M, Leite-de-Moraes MC, Bach JF, Vargaftig BB, Herbelin A.

Eur J Immunol. 2004 Feb;34(2):327-35.

16.

Eosinophilopoiesis in a murine model of allergic airway eosinophilia: involvement of bone marrow IL-5 and IL-5 receptor alpha.

Tomaki M, Zhao LL, Lundahl J, Sjöstrand M, Jordana M, Lindén A, O'Byrne P, Lötvall J.

J Immunol. 2000 Oct 1;165(7):4040-50.

17.

Invariant NKT cells act as an adjuvant to enhance Th2 inflammatory response in an OVA-induced mouse model of asthma.

Nie H, Yang Q, Zhang G, Wang A, He Q, Liu M, Li P, Yang J, Huang Y, Ding X, Yu H, Hu S.

PLoS One. 2015 Apr 1;10(4):e0119901. doi: 10.1371/journal.pone.0119901. eCollection 2015.

18.

Differential capacity of CD8+ alpha or CD8- alpha dendritic cell subsets to prime for eosinophilic airway inflammation in the T-helper type 2-prone milieu of the lung.

Hammad H, de Vries VC, Maldonado-Lopez R, Moser M, Maliszewski C, Hoogsteden HC, Lambrecht BN.

Clin Exp Allergy. 2004 Dec;34(12):1834-40.

PMID:
15663556
19.

Inhibition of airway eosinophilia and pulmonary pathology in a mouse model of allergic asthma by the live vaccine strain of Francisella tularensis.

KuoLee R, Zhou H, Harris G, Zhao X, Qiu H, Patel GB, Chen W.

Clin Exp Allergy. 2008 Jun;38(6):1003-15. doi: 10.1111/j.1365-2222.2008.02956.x. Epub 2008 Feb 26.

PMID:
18307525
20.

A critical role for IFN regulatory factor 1 in NKT cell-mediated liver injury induced by alpha-galactosylceramide.

Cao Z, Dhupar R, Cai C, Li P, Billiar TR, Geller DA.

J Immunol. 2010 Aug 15;185(4):2536-43. doi: 10.4049/jimmunol.1000092. Epub 2010 Jul 12.

Supplemental Content

Support Center